GPP
ATRS

Great Point Partners’s Antares Pharma, Inc. ATRS Stock Holding History

Great Point Partners’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-500,000
Closed -$1.1M – 48
2018
Q1 		$1.1M Buy
+500,000
New +$1.13M 0.16% 33
2015
Q4 		– Sell
-1,018,627
Closed -$1.73M – 30
2015
Q3 		$1.73M Sell
1,018,627
-1,781,373
-64% -$3.49M 0.69% 27
2015
Q2 		$5.82M Buy
+2,800,000
New +$6.79M 2.27% 16

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Great Point Partners's ATRS Position: Q2 2018 in Review

Great Point Partners sold out of Antares Pharma, Inc. (ATRS) in Q2 2018, closing a stake of 500,000 shares — an estimated $1.1M sold.

Great Point Partners first reported a position in ATRS in Q2 2015 and held it in 3 quarters. The position peaked at $5.82M in Q2 2015. 101 funds tracked by Wall St. Rank hold ATRS as of Q2 2018.

  • Great Point Partners reported no remaining Antares Pharma, Inc. position as of Q2 2018 after selling out during the quarter.
  • Great Point Partners sold 500,000 Antares Pharma, Inc. shares in Q2 2018, an estimated $1.1M.
  • Great Point Partners first reported a position in Antares Pharma, Inc. in Q2 2015 and held it in 3 quarters.
  • Great Point Partners's Antares Pharma, Inc. position peaked at $5.82M in Q2 2015.
  • 101 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2018.

Based on Great Point Partners's 13F filing for Q2 2018, filed 14 Aug 2018.